Energy expenditure and substrate oxidation rates of obese rats during a 12-day treatment with dexfenfluramine

Annals of Nutrition and Metabolism

Volumn 40, Issue 1, 1996, Pages 10-23

  Boschmann, M ^a   Aust, L ^a   Frenz, U ^a   Noack, R ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Amino acids; Calorimetry; Dexfenfluramine; Energy metabolism; Free fatty acids; Glucose; Glycogen; Insulin; Obesity; Pyruvate kinase

Indexed keywords

AMMONIA; ARGININE; CITRULLINE; DEXFENFLURAMINE; FATTY ACID; GLUCOSE; GLUTAMINE; GLYCOGEN; INSULIN; ORNITHINE; PYRUVATE KINASE; UREA;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID OXIDATION; MALE; NERVE CELL NETWORK; NITROGEN URINE LEVEL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RESPIRATORY QUOTIENT; UREA BLOOD LEVEL;

EID: 0029927692     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000177893     Document Type: Article

References (48)

1. Blundell J: Pharmacological approaches lo appctile suppression. Trends Pharmacol Sci 1991:12: 149-157.
2. Bray G: Nutrient balance: New insight into obesity. Int J Obes 1987; 11 (suppl 3):83-95.
3. Brindley DN: Neuroendocrine regulation and obesity. Int J Obes 1992: 16(suppl 3):73-79.
4. Samanin R, Garatini S: Neurochcm-ical mechanism of action of anorectic drugs. Pharmacol Toxicol 1993; 73:63-68.
5. Wurtman J, Wurtman R: Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 1977; 198:178-180.
6. Wurtman J. Wurtman R: Drugs that enhance central serotonergic transmission diminish selective carbohydrate consumption by rats. Life Sci 1980:24:823-826.
7. Shor-Posner G, Grinker JA, Mari-nescu C, Brown O, Leibowitz SF: Hypothalamic serotonin in the control of meal patterns and macronu-tricnt selection. Brain Res Bull 1986:17:663-671.
8. Guy-Grand B, Apfelbauni M, Cre-paldi G, Gries A, Lefcbvre P, Turner P: International trial of long-term dexfenfluramine in obesity. Lancet 1989;ii:l142-1145.
9. Garratini S. Bizzi A. Caccia S. Men-nini T: Progress report on the anorectic effects of dexfenfluramine. fluoxetine and sertraline. Int J Obes 1992; 16(suppl 3):43-50.
10. Rowland NE, Carton J: Dcxfenflu-ramine: Effects on food intake in various animal models. Clin Neuro-pharmacol 1988:11 (suppl I):33-50.
11. Levitsky DA. Schuster JA. Stallone DD. Strupp BJ: Modulation of the thermic effect of food by fenfluramine. Int J Obes 1986:10:169-173.
12. Lupin JR, Tokunaga K, Kemnitz JW, Groos E, Bray GA: Lateral hypothalamic lesions and fenfluramine increase thcrmogenesis in brown adipose tissue. Am J Physiol 1986; 25:R1221-R1227.
13. Rothwell NJ. LcFeuvrc RA: Ther-mogcncsis: Brown adipose tissue and dexfenfluramine in animal studies. Int J Obes 1992; 16(suppl 3): 67-71.
14. McCormack JG. Dean HG. Jennings GJ. Blundell JE: Effect of chronic low doses of t-fenfluramine on weight gain and caloric intake, brown adipose tissue thermogenic parameters and brain neurotrans-mittcr content in rats fed chow or palatable diets. Int J Obes 1989:13: 625-633.
15. Geelen MJH: Effects of fenfluramine on hepatic intermediary metabolism. Biochem Pharmacol 1983:32: 3321-3324.
16. Sasson S, Kunievsky B, Nathan C, Cerasi E: On the role of 5-hvdroxy-tryptaminc in the peripheral action of fenfluramine: Studies with the isolated rat soleus muscle. Biochcm Pharmacol 1990:39:965-968.
17. Even P. Nicolai'dis S: Metabolic mechanism of the anorectic and lep-togenic effects of the serotonin agonist fenfluramine. Appetite 1986; 7(suppl): 141-163.
18. Even P. Coulaud H. Nicolai'dis S: Lipostatic and ischymetric mechanisms originate dexfenfluramine-in-duced anorexia. Pharmacol Biochem Behav 1988:30:89-99.
19. Scheurink AJW, Leuvenink H. Ben-them B, Steffens AB: Dexfeniluram-ine influences plasma catecholamines and energy substrate metabolism in rats. Physiol Behav 1983: 53:879-887.
20. Boschmann M, Frenz U, Noack R, Aust L, Murphy C: Energy metabolism and metabolite patterns of rats after application of dexfenfluram-inc. Int J Obes 1994:18:235-242.
21. Boschmann M, Frenz U, Murphy C, Noack R: Obesity, serotonergic transmission and metabolism (abstract). FASEB J 1994:8:172.
22. Widdowson EM: Rearing rats in large and small groups. Proc Nutr Soc 1980:302.
23. Knittlc JL. l lirsch J: Effect of early nutrition in the development of rat epididvmal fat pads: Cellularity and metabolism. J Clin Invest 1968:47: 2091-2098.
24. Aubert R, Suquet I, Lcmonnier D: Long-term morphological and metabolic effects of early under- and ovemutrition in mice. J Nutr 1980: 110:649-661.
25. l4C-i-acetate into liver and plasma lipids of post-natally overfed rats. Nahrung 1982: 26:115-156.
26. Duff D. Snell K: Effect of altered neonatal nutrition on the development of enzymes of lipid and carbohydrate metabolism in the rat. J Nutr 1982;112:1057-1066.
27. Fclig P: Amino acid metabolism in man. Annu Rev Biochem 1975:44: 933-955.
28. Gianotti M, Roca P, Palou A: The effects of cafeteria diet induced obesity on rat blood amino acid com-partmentation. Arch Int Physiol Biochim 1990:98:155-161.
29. Serra F. Johnston J. Camic J. Palou A: Altered blood amino acid distribution in genetically obese mice. Biochim Biophys Acta 1991:1097: 289-292.
30. Bergmeyer HU (ed): Methods of Enzymatic Analysis, ed 3. Weinheim. Verlag Chemie, 1983.
31. Algermissen B. Niindcl M. Riedel E: Analytik von Aminosäuren mit Fluoreszcnz-HPLC. GIT 1989:33: 783-790.
32. Frenz U, Aust L, Noack R: Calculating energy utilization factors and locomotor activity from calorimctric measurements. Thermochim Acta 1995:251:271-281.
33. Fernström JD. Wurtman RJ: Brain serotonin content: Increase following ingestion of carbohydrate diet. Science 1971:174:1023-1024.
34. Fernström JD. Wurtman RJ: Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 1972:178:414-416.
35. Brindley DN. Saxton J. Shahidullah H. Armstrong M: Possible relationships between changes in body weight set-poinl and stress metabolism after treating rats chronically with t-fenfluramine. Biochem Pharmacol 1985;34:1265-1271.
36. Rozen R, Fumeron F, Betoulle D, Baigts F, Mandenof T A, Frickcr J, Apfclbaum M: Permanent administration of ¿-fenfluramine in rats: Paradoxical effects. Clin Ncuro-pharmacol 1988; 11 (suppl 1): 105-112.
37. Levitsky DA, Troiano R: Metabolic consequences of fenfluramine for the control of body weight. Am J Clin Nutr 1992:55(suppl 1): 167-172.
38. Sehaechter JD. Wurtman RJ: Effect of chronic d-fenfluramine administration on rat hypothalamic serotonin levels and release. Life Sci 1989; 44:265-271.
39. Rowland NE, Carlton J: Tolerance to fenfluramine anorexia: Fact or fiction? Appetite 1986:7(suppl):71-83.
40. Schdnfeld P, Schild L, Kunz W: Long-chain fatty acids act as proton-ophorctic uncouplers of oxidative phosphorylation in rat liver mitochondria. Biochem Biophys Acta 1989:977:266-272.
41. Skulachev V: Fatty acid circuit as a physiological mechanism of uncoupling of oxidative phosphorylation. FEBS Lett 1991:294:158-162.
42. Rowland NE. Carlton J: Neurobiology of an anorectic drug: Fenfluramine. Prog Neurobiol 1986:27:13-62.
43. Storlicn LH, Thornbum AW, Smyth GA, Jenkins AB, Chrisholm DJ, Kraegen EW: Effect of d-fenfluramine on basal glucose turnover and fat-feeding-induced insulin resistance in rats. Diabetes 1989:38: 499-503.
44. Andersen PH. Richclsen B. Bak J. Schmitz O. Sorensen NS. Lavielle R. Pedersen O: Influence of shori-term dexfenfluramine therapy on glucose and lipid metabolism in obese nondiabetic patients. Acta Endocrinol 1993:128:251-258.
45. Greco AV. Mingronc G, Tataranni PA. Raguso C, Degaetano A. Tac-chinop RM. Lavielle R. Ghirlanda G: Turnover and oxidation rates of plasma free fatty acids in obese patients treated with dexfenfluramine. Ann NutrMctab 1993;37:237-244.
46. Frexcs-Steed M, Lacy DB. Collins J, Abumrad NN: Role of leucine and other amino acids in regulating protein metabolism in vivo. Am J Physiol 1992;262:E925-E935.
47. Leibowitz SF: The role of serotonin in eating disorders. Drugs 1990;39: 33-48.
48. Smith RJ: Glutamine metabolism and its physiologic importance. J PEN 1990;14(suppl):40-44.